Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04286581 · ClinicalTrials.gov registry record · NA

Comparison of Ambu Auragain and I-Gel Supraglottic Airways in Adult Patients at an Ambulatory Surgery Center

A NA study of Surgery and Anesthesia, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
148
Enrollment target
1
Study location

NCT04286581 is a NA study of Surgery and Anesthesia that has completed, run by University of Minnesota. The registered enrollment target is 148 participants, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04286581, a NA study of Surgery and Anesthesia, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
148 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if an I-gel laryngeal mask airway (LMA) has a higher oropharyngeal leak pressure compared to an Ambu Auragain in adult patients in an ambulatory surgery center.

Conditions Studied

Interventions

  • DEVICE I-Gel Laryngeal Mask Airway
  • DEVICE Ambu Auragain Laryngeal Mask Airway

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 148 participants
Start Date 2021-03-22
Est. Completion 2021-10-31
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT04286581

The ClinicalTrials.gov registry entry for NCT04286581 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Surgery appearing as the primary indexed condition, and to 2 interventions - of which I-Gel Laryngeal Mask Airway is the first listed.

NCT04286581 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT04286581 about?

NCT04286581 is a clinical study titled "Comparison of Ambu Auragain and I-Gel Supraglottic Airways in Adult Patients at an Ambulatory Surgery Center". The purpose of this study is to determine if an I-gel laryngeal mask airway (LMA) has a higher oropharyngeal leak pressure compared to an Ambu Auragain in adult patients in an ambulatory surgery center.

What is the current status of trial NCT04286581?

This trial is currently completed. It is a NA study. The enrollment target is 148 participants. The study started on 2021-03-22. Estimated completion is 2021-10-31.

What conditions does trial NCT04286581 study?

This clinical trial studies the following conditions: Surgery, Anesthesia.

What interventions are being tested in trial NCT04286581?

The interventions under investigation include: I-Gel Laryngeal Mask Airway (DEVICE), Ambu Auragain Laryngeal Mask Airway (DEVICE).

Who is sponsoring clinical trial NCT04286581?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04286581 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.